Русский
Cancers of urinary system, prevalence, demographic
DOI: https://dx.doi.org/10.18565/urology.2019.6.74-77
Z. Tolou Ghamari, H. Mazdak
1) Isfahan Kidney Transplantation Research Center; 2) Department of Urology, Isfahan University of Medical Sciences. Isfahan, Iran
Background: The aim of this study was to clarify period prevalence (PP) and incidence associated to urinary system cancers in Isfahan Province/Iran.
Methods: Data from 2011 to 2015 was obtained from the Isfahan Cancer Registry. The location of cancers was distinguished by the related established topography code (C64-C68). Period prevalence (PP) was calculated and expressed per 100000 persons.
Results: There were 2117 patients with urinary system cancers. The mean age ± SD was 63.6±14.9 years old, that in 62% ranged between 20 and 70 years old. For total population the PP was calculated as 42. 5 per 100000 persons. This value was corresponded to PP of 66.4 for males and 17.9 for females (p<0.001). The total PP was corresponded to values of 33.2 for bladder, 8.1 for kidney, 0.42 for renal pelvis, 0.36 for ureter and 0.38 for other unspecified related organs. Of these populations the estimated living cases corresponded to the 368 females and 1513 males.
Conclusion: The PP for urinary system cancers in male population was 3.7 times higher than females. There was a 23.2% increase in the Irs over the study period. These findings highlighted the advantage of further strategy base-research toward pharmacotherapy and surgery management of such patients.
Methods: Data from 2011 to 2015 was obtained from the Isfahan Cancer Registry. The location of cancers was distinguished by the related established topography code (C64-C68). Period prevalence (PP) was calculated and expressed per 100000 persons.
Results: There were 2117 patients with urinary system cancers. The mean age ± SD was 63.6±14.9 years old, that in 62% ranged between 20 and 70 years old. For total population the PP was calculated as 42. 5 per 100000 persons. This value was corresponded to PP of 66.4 for males and 17.9 for females (p<0.001). The total PP was corresponded to values of 33.2 for bladder, 8.1 for kidney, 0.42 for renal pelvis, 0.36 for ureter and 0.38 for other unspecified related organs. Of these populations the estimated living cases corresponded to the 368 females and 1513 males.
Conclusion: The PP for urinary system cancers in male population was 3.7 times higher than females. There was a 23.2% increase in the Irs over the study period. These findings highlighted the advantage of further strategy base-research toward pharmacotherapy and surgery management of such patients.
Similar Articles
